ImmunityBio converts from Immunomedics | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
ImmunityBio converts from Immunomedics

An SI Board Since February 2023

Posts	SubjectMarks	Bans	Symbol
1504	51	0	IBRX

Emcee: TinfoilHat	Type: Moderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
810	It seems odd to me that you own IBRX without a deep understanding of PSS, since	End2War	1	1/13/2025
809	Not impressed with PSS, and couldn't disagree more on many of his views, etc	galt	3	1/13/2025
808	Wide ranging podcast/interview with PSS who is in Washington to talk to FDA toda	End2War	1	1/13/2025
807	“As was indicated by his comments before the latest tank job” Can I ask what com	CCS648	-	1/12/2025
806	We admit to being pretty relaxed about IBRX and its future. Simply put, if Ankt	bobbseytwins2001	8	1/12/2025
805	Agree with you on the pricing of the offfering. The good news is that someone sn	galt	5	1/12/2025
804	Price target of 6? I’m so excited.	jargonweary	2	1/12/2025
803	JPM Conference Wednesday 2:15	Redman1234	-	1/12/2025
802	I recommended your post as whimsy, and unfortunately I think that the investment	Fitzhughlaw	4	1/12/2025
801	While Brexit separated the MHRA from the EMA, it didn’t drastically change the M	Redman1234	1	1/12/2025
800	On Friday, BTIG initiated coverage on ImmunityBio Inc (NASDAQ:IBRX) with a Buy r	erippetoe	-	1/11/2025
799	Similarly theres the Accelerated Assessment path for EMA. The average market aut	Redman1234	3	1/10/2025
798	Drug applications in the UK can be submitted through multiple routes for approva	Redman1234	2	1/10/2025
797	I missed buying in the 1s the last time. Waiting for another chance, but not w/	Stanley Lake 92	-	1/10/2025
796	The whole market is tanking because US payroll grew by much more than expected.	Redman1234	3	1/10/2025
795	Becoming a debacle. The science seems great and yet the market is saying there	TripleE3	-	1/10/2025
794	If only Behzad would come to the rescue again ............. :)	luckydog88	1	1/10/2025
793	ImmunityBio Announces Permanent J-code (J9028) for ANKTIVA® Is Now Effectiv	erickerickson	4	1/6/2025
792	stkt.co	Redman1234	2	1/4/2025
791	From ST board poster huggenberg. “This statement should be reconsidered because	Redman1234	-	1/4/2025
790	ImmunityBio follows through in lung cancer 3 January 2025 oncopipeline.com A new	dorightbythem	4	1/4/2025
789	$37,000 per vial. Now we know. This is major. Once this sinks in expecting publi	Redman1234	4	1/2/2025
788	Also discussion on calculation of Medicare J code reimbursing price? stkt.co	Redman1234	-	1/2/2025
787	From ST board. FiercePharma Jan 2, 2025 article stkt.co	Redman1234	1	1/2/2025
786	Loaded up. Looks that we could begin the slow climb back to 7, hopefully in firs	galt	5	1/1/2025

Go to reply# or date (mm/dd/yy):